找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Inflammatory Cardiomyopathy (DCMi) - Pathogenesis and Therapy; Heinz-Peter Schultheiss,Michel Noutsias Book 2010 Birkh?user Basel 2010 ant

[復(fù)制鏈接]
樓主: Fatuous
31#
發(fā)表于 2025-3-26 22:42:10 | 只看該作者
32#
發(fā)表于 2025-3-27 01:47:59 | 只看該作者
33#
發(fā)表于 2025-3-27 06:06:20 | 只看該作者
The role of cytokines in inflammation-induced cardiomyopathy: Pathogenesis and therapeutic implicatiprocess of cardiac remodeling and prognosis. A complex relationship seems to exist between the adaptive and maladaptive immune response, cytoprotective, growth, and contractile effects of inflammatory mediators. Understanding the mechanisms underlying this innate cytoprotection has the potential to
34#
發(fā)表于 2025-3-27 10:11:04 | 只看該作者
Histology and immunohistology of myocarditisyopathy) among the primary cardiomyopathies (predominantly involving the heart) as opposed to the secondary forms (mainly involving the heart in the setting of generalized systemic disease). Endomyocardial biopsy (EMB) is still considered the gold standard for the in vivo diagnosis of myocarditis, i
35#
發(fā)表于 2025-3-27 14:56:20 | 只看該作者
Immunohistological diagnosis of inflammatory cardiomyopathy and diagnosis of cardiotropic viral infeinflammation and/or viral infection in endomyocardial biopsies (EMBs). The immunohistological evaluation of EMBs, comprising the quantification of infiltrates and of cell adhesion molecule expression, has proven substantially more sensitive and specific compared with the histological EMB investigati
36#
發(fā)表于 2025-3-27 19:49:35 | 只看該作者
Cardiac magnetic resonance imaging: A non-invasive approach for the detection of myocardial inflammafferent cardiac diseases. Furthermore, it is capable of tissue characterization using T1- and T2-weighted images with and without the use of contrast agents. Therefore, it is the ideal imaging modality in cardiomyopathies or ischemic heart disease. Currently, the most commonly used CMR technique is
37#
發(fā)表于 2025-3-28 00:41:51 | 只看該作者
38#
發(fā)表于 2025-3-28 03:07:39 | 只看該作者
39#
發(fā)表于 2025-3-28 09:40:10 | 只看該作者
40#
發(fā)表于 2025-3-28 11:10:15 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 18:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
偃师市| 宿迁市| 石城县| 昭平县| 新丰县| 镇康县| 辽中县| 肃南| 囊谦县| 偃师市| 墨脱县| 治县。| 阜南县| 太湖县| 和静县| 田东县| 怀宁县| 南丰县| 玉龙| 噶尔县| 偃师市| 南华县| 梁山县| 榆中县| 上虞市| 阜新| 乾安县| 修武县| 青龙| 密山市| 疏附县| 定安县| 镇安县| 新河县| 中阳县| 微山县| 湘乡市| 塔河县| 蒙城县| 重庆市| 晋州市|